N-Power Medicine raises $32m Series B to expand oncology research
The financing supports a larger community-oncology network and new ProECA programs in colorectal and prostate cancer.
Innovatus Capital Partners, Labcorp Venture Fund and Merck Global Health Innovation Fund backed the round.
N-Power plans to scale its research network and deepen pharmaceutical partnerships. Its existing non-small-cell lung cancer ProECA program operates at more than 40 community sites, providing a base for expansion into other cancers.
The prospective external-control-arm model uses trial-grade information from routine care, linking the network expansion to comparison data for cancer drug developers.
Use of funds
Scale community oncology research network
Deepen pharmaceutical partnerships
Expand ProECA programs into colorectal and prostate cancer